We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Fuchs joins Provectus advisory board

Fuchs joins Provectus advisory board

July 15, 2011
CenterWatch Staff

Provectus Pharmaceuticals, a development-stage oncology and dermatology biopharmaceutical company, has named Stuart Fuchs to its corporate advisory board. He is resigning from the board of directors.

Fuchs was previously a co-founder and managing principal of Gryffindor Capital Partners and before that was with Goldman Sachs for 19 years. Before becoming an investment banker, he practiced law. He also serves as chairman and CEO of CognoSPECTi, a start-up venture.

Dr. Craig Dees, PhD., CEO of Provectus said, “Stuart has provided many years of service to Provectus Pharmaceuticals as a member of our board of directors. As we transition our board of directors to becoming an independent board, Stuart, who has been a consultant to Provectus Pharmaceuticals, has agreed to transition off our board of directors, and join our corporate advisory board, where he will still remain active as an advisor to our company.”

Global News Awards & Advancement

Upcoming Events

  • 09Dec

    The Age of eSource: Modernizing Clinical Trials

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Patient-phsyician-consultation

    Giving Patients Back Their Voice in Clinical Trials

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing